Temporal Spatial and Metabolic Measures of Walking in Highly Functional Individuals With Lower Limb Amputations by Jarvis, HL et al.
Accepted Manuscript
Temporal spatial and metabolic measures of walking in highly functional individuals
with lower limb amputations
Hannah L. Jarvis, PhD, Alex N. Bennett, PhD FRCP, Martin Twiste, PhD, Rhodri D.
Phillip, FRCP, John Etherington, FRCP OBE, Richard Baker, PhD
PII: S0003-9993(16)31230-8
DOI: 10.1016/j.apmr.2016.09.134
Reference: YAPMR 56719
To appear in: ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
Received Date: 29 April 2016
Revised Date: 13 September 2016
Accepted Date: 30 September 2016
Please cite this article as: Jarvis HL, Bennett AN, Twiste M, Phillip RD, Etherington J, Baker R,
Temporal spatial and metabolic measures of walking in highly functional individuals with lower limb
amputations, ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2016), doi: 10.1016/
j.apmr.2016.09.134.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Temporal spatial and metabolic measures of individuals with lower limb amputations 
 
Temporal spatial and metabolic measures of walking in highly functional individuals 
with lower limb amputations 
Hannah L Jarvis, PhD1,2# 
Alex N Bennett, PhD FRCP3,4,5 
Martin Twiste, PhD2,4 
Rhodri D Phillip, FRCP3 
John Etherington, FRCP OBE3 
Richard Baker, PhD1 
 
1 Department of Exercise and Sport Science, Manchester Metropolitan University, Crewe 
Campus, CW1 5DU 
2 School of Health Sciences, University of Salford, Salford, M6 6PU, UK 
3
 Defence Medical Rehabilitation Centre, Headley Court, Epsom, Surrey, KT18 6JW, UK 
4 United National Institute for Prosthetics & Orthotics Development (UNIPOD), University 
of Salford, Salford, M6 6PU, UK 
5 Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds 
6 National Heart and Lung Institute, Faculty of Medicine, Imperial College London 
 
Word count 2,981 (manuscript text without abstract, acknowledgements or references) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Temporal spatial and metabolic measures of individuals with lower limb amputations 
 
 
#Corresponding author: 
Dr Hannah Jarvis 
Address: Department of Exercise and Sport Science, Manchester Metropolitan University, 
Crewe Campus, CW1 5DU 
Email: h.l.jarvis@salford.ac.uk 
 
Acknowledgments 
Mr Mark Thoburn (BSc (Hons) Prosthetics and Orthotics), Lead Clinical Prosthestist, 
DMRC, Headley Court and Gillian Conway BSc (Hons) Prosthetics and Orthotics) were 
instrumental in supporting the logistics of data collection, giving advice on prosthetic 
componentry and obtaining clinical data. 
 
Conflicts of Interest 
The authors declare that there are no conflicts of interest
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Temporal spatial and metabolic measures of individuals with lower limb amputations 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Temporal spatial and metabolic measures of walking in highly functional individuals 1 
with lower limb amputations 2 
Abstract  3 
Objective 4 
The aim of this descriptive exploratory study is to record the temporal spatial parameters and 5 
metabolic energy expenditure during walking of individuals with amputation, walking with 6 
advanced prostheses and following completion of comprehensive rehabilitation, to able-7 
bodied controls. 8 
 9 
Design 10 
Cross-sectional 11 
 12 
Setting 13 
Multi-disciplinary comprehensive rehabilitation centre 14 
 15 
Participants  16 
Thirty severely injured United Kingdom military personnel with amputation and subsequent 17 
completion of their rehabilitation programme (10 unilateral trans-tibial, 10 unilateral trans-18 
femoral, and 10 bilateral trans-femoral) were compared to (and of similar age, height and 19 
mass (p >0.537) as) 10 able-bodied controls.  20 
 21 
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Interventions  22 
Not applicable 23 
 24 
Main Outcomes and Measures 25 
Temporal spatial and metabolic energy expenditure data were captured during walking on 26 
level ground at self-selected speed. 27 
 28 
Results 29 
The individuals with amputation were all male, with a mean age 29 years (SD = 4) and mean 30 
New Injury Severity Score of 31 (SD = 16). Walking speed, stride length, step length and 31 
cadence of individuals with a unilateral trans-tibial or trans-femoral amputation was 32 
comparable to controls, and only for individuals with a bilateral trans-femoral amputation 33 
was walking speed significantly slower (1·12m/s, p = 0.025) and cadence reduced (96 34 
steps/min, p = 0.026). Oxygen cost for individuals with a unilateral trans-tibial amputation 35 
(0·15 ml/kg/m) was the same as for controls (0·15 ml/kg/m), and significantly increased by 36 
20% (0·18ml/kg/m, p = 0.023) for unilateral trans-femoral and by 60% (0·24 ml/kg/m, p < 37 
0.001) for bilateral trans-femoral individuals with amputation. 38 
 39 
Conclusion  40 
The scientific literature reports a wide range of gait and metabolic energy expenditure across 41 
individuals with amputation. The results of this study indicate that the individuals with 42 
amputation have a gait pattern which is highly functional and efficient. This is comparable to 43 
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a small number of studies reporting similar outcomes for individuals with a unilateral trans-44 
tibial amputation, but the results from this study are better than those on individuals with 45 
trans-femoral amputations reported elsewhere, despite comparison with populations wearing 46 
similar prosthetic componentry. Those studies that do report similar outcomes have included 47 
individuals who have been provided with a comprehensive rehabilitation programme. This 48 
suggests that such a programme may be as important as, or even more important than, 49 
prosthetic component selection in improving metabolic energy expenditure. The data are 50 
made available as a benchmark for what is achievable in the rehabilitation of some 51 
individuals with amputations, but agreeably may not be possible for all amputees to achieve. 52 
 53 
Keywords 54 
Amputation, rehabilitation, gait 55 
 56 
List of abbreviations 57 
IED Improvised Explosive Device 58 
NISS New Injury Severity Score 59 
RTA Road Traffic Accident 60 
NHS National Health Service 61 
KD Knee disarticulation 62 
BKD Bilateral knee disarticulation 63 
TT Trans-tibial 64 
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IED Improvised explosive device 65 
GSW Gunshot wound 66 
TF Trans-femoral 67 
LPPR Low profile reflex rotate 68 
TSB Total surface bearing 69 
IC Ischial containment 70 
IBS Ischial bearing socket 71 
DEB Distal end bearing 72 
  73 
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Temporal spatial and metabolic measures of walking in highly functional individuals 74 
with amputations 75 
Introduction 76 
Provision of prostheses and rehabilitation care for individuals with amputation is becoming 77 
increasingly important. The changing nature of modern warfare, highlighted by recent 78 
conflicts in Afghanistan and Iraq, has resulted in many service members suffering severe and 79 
life threatening injuries, often resulting in traumatic amputation of one or more limbs. In 80 
civilian populations, the aftermaths of current or previous wars and road traffic and work-81 
based accidents are still a major cause of traumatic amputation. Events such as the 82 
Paralympics and Invictus games have highlighted the high functionality of some individuals 83 
and thus have increased the expectations among both individuals with amputation (whatever 84 
the cause) and wider society for high quality prostheses and rehabilitation outcomes.  85 
Understanding the outcomes that individuals who have had amputations can expect from their 86 
rehabilitation programme and prosthetics provision is thus becoming increasingly important. 87 
In the scientific literature, however, there is considerable variation in the results of studies 88 
which have set out to document how individuals with amputation walk. Some studies, for 89 
example, have measured individuals with a unilateral trans-tibial amputation as walking at 90 
the same speed, stride and step length and with similar metabolic energy expenditure 91 
compared to the able-bodied. (1-3) Other studies report substantial differences between 92 
individuals with a unilateral trans-tibial amputation and the able-bodied of up to 53%.(4) 93 
Individuals who have had a trans-femoral amputation also show considerable variability with 94 
reported metabolic energy expenditure from 33% and up to 73% (1, 4-8) of values for the able-95 
bodied. 96 
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Such variability could arise from a number of sources with the most obvious being cause of 97 
amputation, prosthetics prescription, other characteristics of the individual, and the nature of 98 
the rehabilitation programme. Both Torburn et al. (9) and Barth et al. (10) have reported that 99 
walking patterns and metabolic energy expenditure are significantly greater in individuals 100 
who have had an amputation as a consequence of vascular disease rather than trauma. For 101 
practical reasons, however, most studies have recruited relatively young and healthy 102 
individuals. Most of these have had amputation as a result of trauma (with a much smaller 103 
number having had cancer or congenital absence or deformities). Given the relative 104 
consistency of cause of amputation across the reported studies, this is unlikely to explain the 105 
variability of results. 106 
Over recent decades there have been considerable advances in prosthetic componentry with 107 
the development of micro-processor knees, dynamic elastic response feet, and powered ankle 108 
units. Although, individuals with amputation express a strong preference for these devices, 109 
studies making a direct comparison between conventional and new componentry have failed 110 
to find clinically significant reductions in metabolic energy expenditure. (4-6, 11-14) Several 111 
studies using essentially similar componentry have recorded quite different levels of 112 
metabolic expenditure, (4, 6, 8, 11) suggesting that the variability is not primarily related to 113 
componentry. 114 
Age of individuals is generally well-reported and the studies showing particularly low levels 115 
of energy ependiture tend to be on younger cohorts. (1, 3) Other individual characteristics, 116 
which might affect walking ability such as general health and motivation, are generally not 117 
well reported (although ability and willingness to participate in formal studies suggests a 118 
certain baseline for both). Another potentially important factor that is generally not 119 
particularly well reported or standardised is the rehabilitation programme. This, supported by 120 
the observation that many of the lowest energy costs of walking in individuals with 121 
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amputation are from the military who may have benefitted from particularly intensive 122 
rehabilitation programmes, focussed on achieving very high levels of function. (1, 3, 15) 123 
In summary high walking efficiency amongst individuals who have had an amputation is 124 
likely to be observed amongst younger, more motivated individuals in good general health 125 
who have state of the art prosthetics prescriptions and who have benefitted from an intensive 126 
rehabilitation programme focussed on achieving high levels of functionality. The cohort of 127 
British servicemen, who have been injured in recent wars and have completed the 128 
rehabilitation programme at the Defence Medical Rehabilitation Centre (DMRC) Headley 129 
Court, have these characteristics. Functional and mental health outcomes indicate that they 130 
have “achieved levels of physical function comparable to healthy age-matched adults” and 131 
had “mental health outcomes indicative of preparedness of full integration back into society”, 132 
even though their original injuries were severe. (16)  133 
Reporting the temporal spatial and metabolic measures of walking outcomes of this group 134 
may thus provide a useful benchmark for future clinical practice both within this 135 
establishment and more widely. The aim of this descriptive exploratory study is thus to 136 
record temporal spatial parameters and metabolic energy expenditure during walking in UK 137 
military personnel with amputation at different levels who have completed the rehabilitation 138 
programme at DMRC Headley Court, and compare these to able-bodied asymptomatic 139 
controls. 140 
 141 
Materials and methods 142 
Participants 143 
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This study was approved by the Ministry of Defence Research Ethics Committee and the 144 
University of Salford ethics panel. Informed verbal and written consent to take part in this 145 
study was obtained from each participant. 146 
Thirty individuals with amputation (10 unilateral trans-tibial, 10 unilateral trans-femoral, and 147 
10 bilateral trans-femoral) were recruited from those available at the time of data collection 148 
between October 2013 and August 2014. This is comparable with other studies of similar 149 
design. (1, 4, 6, 17-20) Inclusion criteria were that they could walk continuously for at least twelve 150 
minutes and had been wearing the same prostheses for at least six months prior to testing. 151 
Prosthetics prescription, including design of socket and type of liner for each individual with 152 
amputation, is presented in Table 1. All bilateral trans-femoral and 3 unilateral trans-femoral 153 
individuals with amputation wore single-axis hydraulic micro-processor knee units such as 154 
the Genium or C-Leg (Otto Bock, Duderstadt, Germany), or Plié (Freeedom Innovations, 155 
Enschede, The Netherlands). The remaining unilateral trans-femoral individuals with 156 
amputation were fitted with a KX06 (Blatchford, Basingstoke, UK) which is a hydraulic 157 
polycentric knee unit (without micro-processor control). Prosthetic feet varied considerably 158 
but were all dynamic elastic response feet. Individuals with amputation who had suffered 159 
from a traumatic brain injury were excluded. All individuals with amputation were 160 
undergoing their rehabilitation programme at DMRC Headley Court. The rehabilitation 161 
programme described in Appendix 1 incorporates the same key components for each patient 162 
and all were managed by the same rehabilitation team at DMRC Headley Court. This utilises 163 
a structured and similar programme for each patient, allowing for individual variation and 164 
needs. Inclusion criteria for controls stated that they must have been asymptomatic for at least 165 
six months prior to testing and without previous major joint or soft tissue surgery. 166 
Demographic data were collected including age, body mass (inclusive of prosthesis mass), 167 
height, New Injury Severity Score (NISS) ,(21) duration of rehabilitation (total time spent at 168 
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DMRC Headley Court for comprehensive rehabilitation), time since injury, prosthetic foot 169 
and knee prescription, socket design and type of liner. An NISS of greater than 15 indicates 170 
major trauma and 75 is the theoretical maximum for someone who survives their injuries. 171 
Outcome measures 172 
Key data variables collected included walking speed, stride and step characteristics, and 173 
metabolic energy expenditure (oxygen consumption per unit time, and oxygen cost per unit 174 
distance). All data were collected simultaneously in the gait laboratory at DMRC Headley 175 
Court. Participants walked for five minutes at self-selected speed. An optoelectronic motion 176 
capture system (Vicon, Oxford, UK) with ten T-Series Vicon cameras and four strain-gauged 177 
force plates (AMTI, Watertown, MA, USA) embedded within a ten metre walkway was used 178 
to capture three-dimensional kinematics and kinetics following the protocol detailed in 179 
Appendix 1. This allowed the calculation of temporal and spatial parameters. Metabolic 180 
energy expenditure measurements were captured using a Metamax (Cortex Biophysik GmbH, 181 
Leipzig, Germany) via indirect calorimetry. All data were normalised to body mass with 182 
prosthesis to allow comparison with previous studies. An average of the rate of oxygen 183 
consumption (ml/kg/min) was calculated over the last minute of data capture for each 184 
participant, and this is divided by walking speed to calculate oxygen cost (ml/kg/m). 185 
 186 
Statistical analysis 187 
No formal hypotheses are being tested and tests of statistical significance are thus taken as 188 
indicative of the relative probability of false positives. No corrections have been applied for 189 
multiple comparisons but the likelihood of this is addressed in the Discussion. All data were 190 
checked for normality using the Kolmogorov Smirnov test. Between group differences across 191 
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the three levels of amputation and the controls were compared using a one-way ANOVA 192 
followed, if statistical significance (P<0.05) was found, by post-hoc analysis of each 193 
amputation level group against control using Least Significant Difference. Other data were 194 
compared using a Kruskall-Wallis test with post-hoc analysis between each group of 195 
individuals with amputation versus control, using individual Mann-Whitney tests. For 196 
between leg comparison (prosthetic versus intact (unilateral individuals with amputation) or 197 
right versus left (bilateral individuals with amputation and controls), parametric data were 198 
compared using an independent t-test and non-parametric data using a Mann-Whitney test. 199 
Statistical analysis was conducted using SPSS (Statistical Package for the Social Sciences) 200 
Version 20 (IBM Corporation, New York, USA). 201 
 202 
Results 203 
Individuals with amputation and controls were of a similar age, height, and mass (Table 1) 204 
(p>0.537 lowest p value for any comparison with controls). Injuries sustained during 205 
operations in Afghanistan or Iraq were the most common cause of amputation with 21 from 206 
improvised explosive devices (IED), 3 from mine, and one from a gunshot wound. Five 207 
required amputation after non-operational injuries, three following road traffic accident 208 
(RTA), and two from other crush injuries. Mean NISS for all individuals with amputation 209 
was 31 which increased with severity of limb loss with unilateral trans-tibial (95% CI 10-22), 210 
compared to unilateral trans-femoral (17-30, p 0.060), and bilateral trans-femoral (44-55, p 211 
<0.001. Individuals with a bilateral trans-femoral amputation required significantly longer 212 
inpatient rehabilitation (22 months, p < 0·001) than those with a unilateral trans-tibial (5 213 
months, p < 0.001), or unilateral trans-femoral amputation (6 months, p <0.001). Prosthetics 214 
prescription for each individual with amputation is presented in Table 1. 215 
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Walking speed, stride length, and cadence of individuals with a unilateral trans-tibial or trans-216 
femoral amputation was comparable to control (p>0.340). 95% confidence intervals for 217 
walking speed of individuals with a unilateral trans-tibial (1·28-1·44 m/s) or unilateral trans-218 
femoral amputation (1·08-1·36 m/s) overlapped considerably that of the controls (1·25-1·33 219 
m/s). Only for individuals with a bilateral trans-femoral amputation was walking speed 220 
significantly slower (1·00-1·24 m/s, p 0·030), and cadence reduced (89-103 steps per minute, 221 
p 0.026) whilst stride length was similar to control (p 0.206, Table 2). For between limb 222 
comparison, stance time was significantly longer for the intact limb (62- 66%) than the 223 
prosthetic limb (60- 62%, p 0.010) for the unilateral trans-tibial group. No other differences 224 
were reported between limbs for other groups. 225 
Oxygen uptake data were not available from three participants with amputation, two 226 
unilateral trans-tibial and one unilateral trans-femoral, due to two not wanting to wear a gas 227 
mask and a failed calibration for the other. The mean rate of oxygen consumption increased 228 
with increasing amputation level but the difference compared with control subjects was only 229 
statistically significant for the bilateral trans-femoral group (43% greater, p = 0.001). Oxygen 230 
cost for individuals with a unilateral trans-tibial amputation (0·13-0·16 ml/kg/m) was the 231 
same as for controls (0·14-0·16 ml/kg/m), and significantly increased by 20% (0·16-0·20 232 
ml/kg/m, p = 0.023) for individuals with a unilateral trans-femoral and by 60% (0·20-0·27 233 
ml/kg/m, p < 0.001) for individuals with a bilateral trans-femoral amputation (Table 2). 234 
 235 
Discussion  236 
The ultimate aim when managing the rehabilitation of an individual with amputation is to 237 
achieve good functional outcomes. Self-selected walking speed, metabolic oxygen cost, and 238 
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gait pattern are all strong indicators of this. The results of this study indicate that the 239 
individuals with amputation in this study have a functional and efficient gait pattern. 240 
Individuals with amputation in this study walked at a similar speed or faster (Figure 1), with a 241 
longer stride length, more symmetrical step length, and narrower stride width than in 242 
comparable studies (4, 6, 8, 12, 18, 19, 22, 23) of groups with similar age, mass and activity level 243 
using similar prosthetic components. Individuals with a unilateral trans-tibial amputation had 244 
the same oxygen cost of walking as the controls which has only been observed in two other 245 
studies (3, 24) (Figure 2). The oxygen cost of walking for individuals with unilateral trans-246 
femoral amputation in this study was only 24% greater than that of the controls. In 247 
comparison, the oxygen cost of walking for individuals with this level of amputation in other 248 
studies (1, 4, 6-8, 11, 25, 26) ranges from 25% (0·20 ml/kg/m)(6) to 50% (0·30 ml/kg/m) (25) greater 249 
than that of controls (Figure 2). The oxygen cost of walking for individuals with a bilateral 250 
trans-femoral amputation in this study is 25% less than the only other reported cohort study, 251 
and individuals with amputation in this study walked significantly faster.(19) In summary, the 252 
data indicate that individuals with amputation in this study perform at least as well as and in 253 
many cases better than those described in the literature in terms of gait function (temporal 254 
spatial parameters) and efficiency (metabolic energy expenditure). 255 
Differences to previous studies are unlikely to be a consequence of the prosthetics 256 
prescription which is similar to previous studies in terms of the characteristics that are likely 257 
to affect level walking in a straight line at self-selected speed. The primary developments in 258 
prosthetics design over the period covered by these studies have focussed on allowing 259 
adaptability in individuals with amputation to walk at different speeds and to cope with 260 
sloped or uneven surfaces. Such developments are only likely to have a minor effect on 261 
studies of walking in laboratory conditions at self-selected speed on a flat surface.  262 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
 
The individuals with amputation cohorts also differ somewhat. As a consequence of either 263 
intentional or unintentional recruitment bias, most studies have been on relatively healthy 264 
individuals with amputation resulting from localised trauma or cancer. The extent of injuries 265 
other than amputation is poorly described in previous studies. The majority of individuals 266 
with amputation in this study have had major life-threatening trauma (as indicated by the 267 
NISS scores) and have sustained a range of other injuries (e.g. gastro-intestinal, genital) and 268 
there is no reason to suspect that other cohorts have walked less well because their 269 
concomitant injuries were more severe.  270 
The positive outcomes found in this study may result from a variety of factors, including 271 
other patient characteristics and the rehabilitation programme. This is a particularly highly 272 
motivated cohort in that many of whom engage in endurance sport (including rowing the 273 
Atlantic and walking across Greenland!). The rehabilitation programme is also likely to be 274 
influential, but poor specification of this in the literature makes detailed comparison difficult. 275 
The length of the military rehabilitation programme that individuals with amputation in this 276 
study have completed is probably of similar length to that in others who report similarly 277 
positive results. (1, 3, 15) Its intensity and focus on the highest levels of functional outcome is 278 
likely to be greater than that of civilian programmes such as those proposed by the British 279 
Society of Rehabilitation Medicine, (27) the British Association of Chartered Physiotherapists 280 
in Amputee Rehabilitation (15) or the Dutch Evidence Based Guidelines For Amputation And 281 
Prosthetics Of The Lower Extremity. (28) Whilst these include recommendations that 282 
individuals are advised about, such as returning to sport and other hobbies, their main focus is 283 
on achieving competence in the activities of daily living. Given the apparent success of this 284 
programme, a fuller description is supplied in Appendix 2. 285 
From this study, we propose that this dataset (more comprehensively documented in 286 
Appendix 3) could be used as a benchmark against which to compare other studies or clinical 287 
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results from individuals with amputation. Nearly all studies compare the walking ability of 288 
individuals with amputation to that of the “normal” able-bodied, which is generally an 289 
unobtainable goal. Instead, comparing the walking ability to individuals with amputations, 290 
but who are rehabilitated to the highest functional level, may be more appropriate. However, 291 
considering the characteristics of each individual with amputation will always be important, 292 
as it may be equally unrealistic to compare outcomes from an elderly and unwell individual 293 
with an amputation due to vascular disease with the outcomes from the young otherwise 294 
healthy individuals with amputation due to trauma reported in this study. (9, 10)  295 
 296 
Study Limitations 297 
There are a number of limitations to this study. Different studies adopt different procedures 298 
for mass normalisation, principally in whether the mass of the prosthesis is included along 299 
with that of the individual. There are arguments for either approach but, perhaps more 300 
importantly, this is not always reported explicitly. All metabolic energy expenditure was 301 
normalised to body mass plus prosthesis which will lead to lower normalised values than 302 
studies normalising to body mass only, and this may account for some of the differences with 303 
previous studies. The aim of this study was to describe the cohorts studied rather than to 304 
detect differences between them, and the p-values were only intended to be indicative of the 305 
strength of results. It can be argued that, whilst many p-values are below 0.05, there is still a 306 
risk of false positives as a consequence of the multiple tests applied. The consistency of 307 
results across a range of outcome measures, however, suggests that this is unlikely. The 308 
generally narrow 95% confidence intervals on most important parameters suggest that the 309 
overall conclusions of the paper are still valid. 310 
 311 
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Conclusions 312 
The findings from this study indicate that individuals with unilateral trans-tibial amputation 313 
can achieve a similar metabolic cost of walking to able-bodied individuals, and the cost of 314 
walking for individuals with uni- and bilateral trans-femoral amputations is lower than in 315 
previous reports. The overall outcome of care for individuals with amputation may be 316 
influenced by a variety of other factors, including age, fitness, and motivation, and the 317 
present results indicate the added importance of participation in an advanced rehabilitation 318 
programme. The programme provided by the authors is one example of advanced 319 
rehabilitation for individuals with amputations that can produce highly functional outcomes 320 
and excellent economy.  321 
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Figure legends 
Figure 1. Comparison of walking speed (mean and standard deviation) in individuals with a 
unilateral trans-tibial and trans-femoral amputation during walking reported by this study and 
others.(3-5, 7, 8, 12, 14, 20, 23, 24, 26) Missing error bars indicate that the standard deviation was not 
provided in source. Solid black line indicates control. In all studies except Schmalz et al (4) 
speeds were identified from over ground walking. All study cohorts are comprised either 
entirely or predominantly of individuals who had amputations as a consequence of trauma. 
All study cohorts wore elastic response feet and micro-processor knee joints except some 
individuals with amputation in.(1, 26) 
Figure 2. Comparison of oxygen cost (mean and standard deviation) in individuals with a 
unilateral trans-tibial and trans-femoral amputation during walking reported by this study and 
others. (1, 3-8, 12, 20, 24, 26, 29) Self-selected walking speed for individuals with amputation except 
(1)
 but similar speed to all other investigations. Missing error bars indicate that the standard 
deviation was not provided in source. Normalisation to body mass and prosthesis used by this 
study, while used normalisation to just body weight (3, 5-8, 20) for (1, 4, 12, 24, 26) methods of 
normalisation not defined. All studies included individuals who had sustained a traumatic 
amputation. All study cohorts wore elastic response feet and micro-processor knee joints 
except.(1, 26) 
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Table 1: Characteristics of participants 
Group Age (years) 
Mass 
(kg) 
Height 
(m) NISS 
Cause 
of amp. 
Duration 
of rehab. 
(months) 
Time 
from injury 
(months) 
Socket 
type 
Socket 
liner 
Torque 
Adaptor 
Prosthetic 
foot 
Prosthetic 
knee 
Unilateral 
trans- 
tibial 
 
23 78·2 1·81 N/A Crush 3·6 12 TSB Iceross sport pin Yes Echelon VT N/A 
29 88·5 1·86 17 IED 11·8 61 PTB none No VSP N/A 
24 119·6 1·86 12 IED 4·2 8 PTB No No Variflex XC N/A 
28 84·9 1·86 29 IED 13·4 33 PTB cushion Yes Echelon VT N/A 
32 94·1 1·85 12 Mine 2·1 69 TSB Iceross pin No Reflex Shock N/A 
28 89·5 1·75 17 IED 5·7 19 TSB Iceross synergy No Echelon VT N/A 
28 84·5 1·80 17 IED 4·9 20 PTB Pin No Reflex Shock N/A 
35 103·7 1·80 5 IED 5·9 19 TSB Pin Yes Echelon VT N/A 
26 87·8 1·90 21 IED 6·3 20 TSB Pin Yes Echelon VT N/A 
24 66·5 1·74 N/A Crush 6·0 7 TSB Pin No Variflex XC N/A 
Mean (SD) 28 (4) 90 (14) 1·82 (0·05) 16 (7)  5 (3) 27 (22)      
Unilateral 
trans- 
femoral 
32 88·8 1·69 24 IED 4·5 39 IBS Seal in liner No Axtion C-LEG 
29KD 85·3 1·78 22 RTA 6·8 8 DEB Seal in No Variflex xc KX06 
35 83·5 1·81 43 Mine 5·2 32 IC Seal in No Reflex shock KX06 
26KD 98·6 1·89 18 IED 4·8 44 DEB Seal in No LPRR Plie 
27KD 94·3 1·80 16 GSW 4·9 26 DEB No No Variflex xc KX06 
27 89·9 1·75 18 IED 6·9 71 IBS No No LPRR KX06 
30KD 83·8 1·87 29 IED 3·5 23 DEB No Yes Elite VT KX06 
27 96·9 1·87 18 Mine 6·7 98 n/n Seal in No Triton HD X3 
27 80·3 1·75 34 RTA 11·4 22 DEB Guardian No Echelon KX06 
35 81·1 1·71 16 RTA 3·8 29 IBS Seal in No Variflex xc KX06 
Mean (SD) 29 (3) 89 (6) 1·81 (0·06) 24 (9)  6 (2) 39 (27)      
Bilateral 
trans- 
femoral 
29 86·7 1·91 36 IED 6·7 32 IC (r) DEB (l) Seal in (r) Alpha cushion (l) No Low profile triton Genium 
24 85·5 1·85 59 IED 7·8 33 Quad Seal in No Axtion C-leg 
28 68·1 1·67 57 IED 12·3 40 n/n Seal in No Axtion C-leg 
28TF/TT 88·8 1·85 50 IED 17·2 27 TSB (l) IC (r) Seal in (r) Activa (l) Yes (l) Triton shock +LPRR Genium 
29 72·9 1·83 41 IED 13·4 46 IC Seal in No LPRR Genium 
34 78·9 1·75 57 IED 12·5 39 IC Seal in No LPRR Genium 
37BKD 88·7 1·89 41 IED 15·9 28 DEB No No LPRR Genium 
29 90·4 1·81 48 IED 10·9 24 IBS Seal in No LPRR Genium 
27 136·2 1·82 50 IED 17·7 32 DEB Seal in (r) Sock fit (l)  No LPRR Genium 
25 70·7 1·76 54 IED 22·1 43 IC Seal in Yes Triton shock Genium 
Mean (SD) 29 (4) 90 (20) 1·82 (0·07) 49 (8)  24 (5) 35 (7) 
     
Control 
Mean (SD) 30 (6) 78 (8) 1·84 (0·07)          
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Table 1: KD knee disarticulation (rather than true trans-femoral amputation). BKD bilateral knee disarticulation. TF/TT trans-femoral and trans-tibial 
amputation (rather than bilateral trans-femoral). LPRR: low profile reflex rotate, RTA: road traffic accident, IED: improvised explosive device, 
Crush: crush injury, GSW: gunshot wound, PTB: patella tendon bearing, TSB: total surface bearing, IC: ischial containment, IBS: ischial bearing 
socket, DEB: distal end bearing, N/A: Not applicable. The duration of rehabilitation listed in Table 1 represents the time spent attending a 
rehabilitation programme at xxxx xxxxxxx xxxxx, whilst time from injury represents the time from injury to when the person attending data 
collection for the study 
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Table 2: Comparison of temporal and spatial parameters, and oxygen consumption and cost between individuals with amputation and control 
groups. 
Parameter Unilateral trans-tibial Unilateral trans-femoral Bilateral trans-femoral Control 
Intact Prosthetic Intact Prosthetic Right Left Right Left 
Walking Speed (m/s) 
 
1·36 +5% 
(1·28- 1·44) 
1·22 -5% 
(1·08- 1·36) 
1·12 -13% 
(1·00- 1·24) 
1·29 
(1·25- 1·33) 
p=0.015 p=0.340 p=0.340 p=0.025  
Stride Length (m) 
 
1·46 -1% 
(1·38- 1·54) 
1·42 -3% 
(1·28- 1·57) 
1·37 -7% 
(1·27- 1·47) 
1·47 
(1·40- 1·54) 
p=0.575 p=0.893 p=0.538 p=0.206  
Stride Width (m) 
 
0·13 +9% 
(0·11- 0·15) 
0·18* +54% 
(0·15- 0·22) 
0·22 +84% 
(0·21- 0·24) 
0·12 
(0·11- 0·13) 
p=<0.0001 p=0.517 p=<0.0001 p=<0.0001  
Cadence (steps/min) 
 
112 +6% 
(107- 117) 
103 -3% 
(97- 109) 
96 -8% 
(89- 103) 
106 
(101- 110) 
p=0.005 p=0.124 p=0.521 p=0.026  
Step Length (m) 
0·73 -1% 
(0·69- 0·78) 
0·73 +0% 
(0·68- 0·77) 
0·72 -3% 
(0·63- 0·80) 
0·71 -3% 
(0·64- 0·78) 
0·69 +8% 
(0·63- 0·74) 
0·69 +7% 
(0·63- 0·75) 
0·74 
(0·70- 0·78) 
0·73 
(0·69- 0·77) 
 p=0.834 p=0.875 p=0.907 p=0.800 
Stance Time (% cycle) 
63·8 +1% 
(62·1- 65·5) 
60·9 -3% 
(60.0- 61.8) 
64·0 +1% 
(61·0- 67·0) 
62·3 -1% 
(60·7- 63·9) 
64·0 +2% 
(61·0- 67·0) 
62·3 +0% 
(60·7- 63·9) 
63·1 
(61·8- 64·.4) 
62·9 
(61·2- 64·6) 
 p=0.010 p=0.336 p=0.983 p=0.853 
O2 Consumption (ml/kg/min) 
 
12·3 +9% 
(11·0- 13·7) 
13·3 +17% 
(11·4- 15·2) 
16·2 +43% 
(13·6- 18·8) 
11·3 
(10·8- 11·9) 
p=0.004 p=0.456 p=0.138 p=<0.0001  
O2 Cost (ml/kg/m) 
 
0·15 +0% 
(0·13- 0·16) 
0·18 +20% 
(0·16- 0·20) 
0·24 +60% 
(0·22- 0·27) 
0·15 
(0·14- 0·16) 
p=<0.0001 p=0.987 p=0.023 p=<0.0001  
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Table 2: p-values in first column are for ANOVA across all four groups where p<0·05. All entries given as the mean with percentage difference relative to 
data from control group and then 95% confidence interval in parenthesis. a asterisks are results of post-hoc comparisons. * statistically significant difference 
from control (p < 0·05). ** statistically significant difference between prosthetic and intact lower limbs (p < 0·05). 
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Figure 1. Comparison of walking speed (mean and standard deviation) in individuals with a 
unilateral trans-tibial or trans-femoral amputation during walking reported by this study and 
others.(3-5, 7, 8, 12, 14, 20, 23, 24, 26) Missing error bars indicate that the standard deviation was not 
provided by source. Solid black line indicates control. In all studies except Schmalz et al (4) 
speeds were identified from over ground walking. All study cohorts are comprised either 
entirely or predominantly of individuals who had amputations as a consequence of trauma. 
All study cohorts wore elastic response feet and micro-processor knee joints except some 
individuals with amputation.(1, 26) 
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Figure 2. Comparison of oxygen cost (mean and standard deviation) in individuals with a 
unilateral trans-tibial or trans-femoral amputation during walking reported by this study and 
others. (1, 3-8, 12, 20, 24, 26, 29) UTT: individuals with a unilateral trans-tibial amputation, UTF: 
individuals with a unilateral trans-femoral amputation. Self-selected walking speed for 
individuals with amputation except (1) but similar speed to all other investigations. Missing 
error bars indicate that the standard deviation was not provided in source. Normalisation to 
body mass and prosthesis (UTT/UTF normalised Body Mass +prosthesis) used by this study, 
while used normalisation to just body weight in this study (UTT/UTF normalised Body 
Mass)  and used by, (3, 5-8, 20) whilst for (1, 4, 12, 24, 26) methods of normalisation not defined. All 
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studies included individuals who had sustained a traumatic amputation. All study cohorts 
wore elastic response feet and micro-processor knee joints except.(1, 26) 
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Appendices 
Appendix 1 Detailed data capture protocol 
The motion capture system (Vicon, Oxford, UK) recorded the locations of retro-reflective 
markers attached to the skin or prosthesis for establishing anatomical coordinate systems of, 
and to track the movement of the pelvis, thigh, shank and foot segments during walking. The 
placement of these markers is described in Appendix Table 1, and demonstrated in Appendix 
Figure 1. Kinematic data were collected at 120Hz and ground reaction forces at 1200Hz. A 
static standing trial was recorded for each participant so to calculate the location of joint 
centres. All data were digitised within Vicon, and then exported for modelling and analysis 
within Visual 3D (C-Motion, Rochelle, USA). A model specific to the height and mass of 
each participant was created. The inertial parameters for each segment are based upon the 
recommendations from De Leva et al.1 Joint kinematics were calculated for the pelvis, hip, 
knee and ankle using inverse dynamics. This allows specific constraints to be applied at the 
joints of the virtual model so to limit rotation and or translation. The pelvis permitted six 
degrees of freedom, but only sagittal, coronal and transverse plane rotation were permitted at 
all other joints. Gait events (initial contact, toe off and initial contact after swing phase) were 
defined from contact with the force plates. All data were normalised to 0-100% of the gait 
cycle and exported as an ASCII. MATLAB (Mathworks, Natrick, MA, USA) was used to 
extrapolate and export the required data to Microsoft Excel for calculation of the GPS as 
similar to described in Baker et al.2  
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Appendix Table1: Marker placement for amputee and control participants 
Segment Marker Placement 
Pelvis 
 
• Markers were placed onto the right and left anterior superior iliac spine and right and left 
posterior superior iliac spine.  
• These were used to define and track this segment 
 
Thigh 
 
• To track the thigh segment three markers were placed onto the mid-point of the anterior 
aspect of the thigh in a triangle cluster formation and another marker placed onto the mid-
point of the posterior aspect of the thigh 
• To define the thigh segment, the hip joint centre was created using recommendations by 
Harrington et al.3 and a marker was placed onto the medial and lateral condyles of the 
femur or onto the knee joint centre of a prosthetic knee. 
 
Shank 
 
• To track the shank segment tour markers were placed in a square cluster formation onto the 
lateral distal aspect of the shank, the socket for trans-tibial amputees or the prosthetic knee 
for trans-femoral amputees. 
• To define the shank segment, markers were placed onto the medial and lateral condyles of 
the femur or the knee joint centre of a prosthetic knee, and the medial and lateral malleloi 
or the equivalent for the prosthetic foot 
 
 
 
Foot 
 
 
 
 
• To track the foot segment a marker were placed on top of the shoe overlaying the mid-point 
of the posterior and lateral aspect of the calcaneus and on top of the 1st, 2nd and 5th 
metatarsal heads. 
• To define the foot segment, markers were placed onto the medial and lateral malleoli and 
metatarsal heads 1 and 5. 
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Appendix Figure 1:  Marker placement for amputee and control participants  
 
 
Appendix 2: Description of rehabilitation programme 
The ethos of the rehabilitation programme starts with early rehabilitation, firstly, during the 
acute phase in hospital, and then, secondly, post-acute phase at xxxx xxxxxxx xxxxx. 
Rehabilitation at xxxx xxxxxxx xxxxx utilising periodic in-patient rehabilitation of between 
two to six weeks at a time, which is segmented with time at home before returning for more 
rehabilitation depending on what is suitable for the patient. Rehabilitation is inter-disciplinary 
with emphasis on managing the physical and psychological consequences of injury. 
Individual and group based sessions utilising physiotherapy, exercise therapy, prostheses 
fitting, and occupational theory are key for individuals with amputation to regain muscular 
strength, co-ordination and control post-injury so that they can learn to walk with their 
prostheses as soon as possible. The mental health team, which includes psychological 
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support, social work and counselling, play an equally important role in helping many patients 
manage the psychological disturbances from war and injury. This includes coming to terms 
with the probable change in career due to medical discharge from military service post-injury, 
and the effect all of the above have on the patient’s family. Rehabilitation continues until the 
inter-disciplinary team agree that optimum possible function has been achieved, mental 
health issues have been addressed, pain is controlled, and appropriate social and vocational 
plans are in place. Due to nature of their potential other injuries all rehabilitation is bespoke 
and guided by patient goal setting, with input from the inter-disciplinary team. Complications 
from those injuries can impact on the rehabilitation in different ways, be it returning to 
hospital for further surgeries or limiting their ultimate functional level – for example spinal 
injuries precluding running and impact work. 
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Appendix 3: Benchmark data 
Appendix 3 Table 1: Temporal spatial parameters, and oxygen consumption and 
oxygen cost for n=10 unilateral trans-tibial individuals with amputation 
 1 2 3 4 5 6 7 8 9 10 
Walking speed  
(m/s) 1.53 1.26 1.17 1.51 1.50 1.30 1.52 1.30 1.25 1.30 
Stride length  
(m) 1.37 1.44 1.35 1.54 1.53 1.33 1.49 1.35 1.80 1.44 
Stride width 
(m) 0.13 0.14 0.20 0.13 0.11 0.09 0.08 0.16 0.12 0.15 
Cadence 
(steps per minute) 134 105 104 118 117 105 1043 109 112 116 
Intact leg step length  
(m) 0.75 0.69 0.70 0.75 0.75 0.65 0.74 0.66 0.92 0.73 
Prosthetic leg step length  
(m) 0.62 0.75 0.65 0.78 0.80 0.69 0.75 0.68 0.85 0.70 
Intact leg stance time 
(% of gait cycle) 63 64 67 60 61 63 63 69 62 66 
Prosthetic leg stance time  
(% of gait cycle) 59 62 62 59 61 60 62 59 62 63 
 
          
Oxygen consumption 
(ml/kg/min) 13.8 10.5 10.0 14.6 10.63 11.2 14.9 13.2 n/d n/d 
Oxygen cost  
(ml/kg/m) 0.15 0.13 0.14 0.16 0.12 0.14 0.16 0.17 n/d n/d 
eTable2: an/d: no data available 
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Appendix 3 Table 2: Temporal spatial parameters, oxygen consumption, and oxygen 
cost for n=10 individuals with a unilateral trans-femoral amputation  
 1 2 3 4 5 6 7 8 9 10 
Walking speed  
(m/s) 1.19 0.96 1.10 1.50 1.12 1.31 1.10 1.60 1.10 1.22 
Stride length  
(m) 1.28 1.04 1.30 1.77 1.34 1.51 1.28 1.77 1.36 1.59 
Stride width 
(m) 0.19 0.30 0.13 0.19 0.12 0.19 0.21 0.13 0.18 0.21 
Cadence 
(steps per minute) 112 111 102 102 100 104 103 109 97 92 
Intact leg step length  
(m) 0.68 0.50 0.65 0.95 0.72 0.69 0.63 0.93 0.67 0.74 
Prosthetic leg step length  
(m) 0.60 0.53 0.65 0.82 0.65 0.82 0.65 0.84 0.69 0.85 
Intact leg stance time 
(% of gait cycle) 61 71 60 59 60 70 69 59 65 66 
Prosthetic leg stance time  
(% of gait cycle) 64 59 64 63 65 59 59 62 62 66 
 
          
Oxygen consumption 
(ml/kg/min) 11.1 13.8 11.2 13.7 11.5 10.3 n/d
a
 18.3 12.3 17.7 
Oxygen cost  
(ml/kg/m) 0.15 0.23 0.17 0.15 0.17 0.13 n/d
a
 0.18 0.20 0.24 
eTable3: an/d: no data available 
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Appendix 3 Table 3: Temporal spatial parameters, oxygen consumption, and oxygen 
cost for n=10 individuals with a bilateral trans-femoral amputation 
 1 2 3 4 5 6 7 8 9 10 
Walking speed  
(m/s) 1.26 1.32 1.10 1.22 0.94 1.03 1.20 0.91 0.90 1.40 
Stride length  
(m) 1.50 n/d
a
 1.21 1.49 1.33 1.18 1.53 1.17 1.36 1.55 
Stride width 
(m) 0.22 n/d
a
 0.21 0.20 0.23 0.22 0.19 0.26 0.22 0.25 
Cadence 
(steps per minute) 99 n/d
a
 109 98 85 104 94 93 79 109 
Right leg step length  
(m) 0.76 n/d
a
 0.59 0.73 0.67 0.60 0.76 0.57 0.68 0.79 
Left leg step length  
(m) 0.77 n/d
a
 0.62 0.76 0.66 0.58 0.77 0.60 0.68 0.75 
Right leg stance time 
(% of gait cycle) 61 71 60 59 60 70 69 59 65 66 
Left leg stance time  
(% of gait cycle) 64 59 64 63 65 59 59 62 62 66 
 
          
Oxygen consumption 
(ml/kg/min) 15.5 20.8 14.6 14.6 12.1 15.7 13.2 15.9 13.3 26.1 
Oxygen cost  
(ml/kg/m) 0.20 0.27 0.22 0.20 0.22 0.26 0.18 0.29 0.25 0.31 
eTable4: an/d: no data available 
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Appendix 3 Table 4: Temporal spatial parameters, oxygen consumption, and oxygen 
cost for n=10 controls (able-bodied/asymptomatic)  
 1 2 3 4 5 6 7 8 9 10 
Walking speed  
(m/s) 1.33 1.30 1.31 1.20 1.32 1.23 1.31 1.39 1.30 1.30 
Stride length  
(m) 1.45 1.45 1.32 1.48 1.38 1.46 1.53 1.52 1.39 1.72 
Stride width 
(m) 0.12 0.15 0.11 0.12 0.12 0.12 0.12 0.12 0.12 0.11 
Cadence 
(steps per minute) 110 107 119 97 115 101 103 110 112 91 
Right leg step length  
(m) 0.73 0.74 0.65 0.81 0.69 0.70 0.75 0.74 0.71 0.87 
Left leg step length  
(m) 0.72 0.72 0.67 0.67 0.69 0.76 0.78 0.78 0.68 0.85 
Right leg stance time 
(% of gait cycle) 61 63 61 63 66 63 63 63 67 61 
Left leg stance time  
(% of gait cycle) 61 63 61 62 66 62 62 69 63 60 
 
          
Oxygen consumption 
(ml/kg/min) 10.9 11.5 11.0 11.2 11.9 13.0 11.9 11.3 9.3 11.3 
Oxygen cost  
(ml/kg/m) 0.14 0.15 0.15 0.14 0.15 0.18 0.15 0.13 0.12 0.15 
 
 
